Choi Cheon-ok, Executive Director of Hallim Pharmaceutical, Reappointed as Public Relations Committee Chair of Korea Pharmaceutical and Bio-Pharma Manufacturers Association

Choi Cheon-ok, Executive Director of Hallim Pharmaceutical, reappointed as Chairman of the Public Relations Committee of the Korea Pharmaceutical and Bio-Pharma Manufacturers Association.

[Asia Economy Reporter Lee Gwan-ju] The Public Relations Committee (hereinafter referred to as PR Committee), a gathering of PR practitioners from pharmaceutical companies under the Korea Pharmaceutical and Bio-Pharma Manufacturers Association, announced on the 8th that Choi Cheon-ok, Executive Director of Hallim Pharmaceutical, has been reappointed as chairman.

On the 7th, the PR Committee held an extraordinary general meeting at the Pharmaceutical Hall in Seocho-gu, Seoul, and reappointed Executive Director Choi Cheon-ok as chairman. The executive team, consisting of Vice Chairman Cha Heun-gyu, Senior Manager of Kukje Pharm, Director Jin Seong-hwan of Samjin Pharmaceutical, General Affairs Manager Choi Jae-ho of Daewon Pharmaceutical, Manager Noh Seok-moon of Anguk Pharmaceutical, and Secretary Team Leader Jeong Chan-woong of the Korea Pharmaceutical and Bio-Pharma Manufacturers Association, were all retained. The term is two years.

Chairman Choi Cheon-ok said, “I am grateful for being entrusted once again with the important role of chairman, and I will do my best together with the executive team to meet both internal and external expectations.”

The PR Committee plans to finalize this year’s budget and key business plans reflecting opinions derived from meetings through a written general meeting soon, and to execute various projects that had been postponed due to COVID-19.

This content was produced with the assistance of AI translation services.